Clinical Trial Update: Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating intratumoral urelumab combined with nivolumab in patients with solid tumors; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Urelumab (urelumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN